CITF, VSRG provide funding for vaccine-related projects

July 20, 2021
The COVID-19 Immunity Task Force (CITF) and the Vaccine Surveillance Reference Group (VSRG) have recently provided funding for several projects related to COVID-19 vaccination, including those led or co-led by Dalhousie University, the University of British Columbia, and the University of Ottawa. Over $8M was invested in four studies led by University of Ottawa and The Ottawa Hospital researchers on how vaccines work on people with immune deficiencies. A project led by Dal’s Dr Karina Top on adverse effects following immunization in authorized vaccines has received $800K. Approximately $770K has been invested in a project co-led by UBC postdoctoral fellow Dr Brittany Barker on the uptake, effectiveness, and side effects of COVID-19 vaccines for members of vulnerable urban populations. CITF (1) | CITF (2) | CITF (3) | Ottawa Citizen (National)